817 filings
Page 8 of 41
8-K
kxmythjg32x8l
24 Apr 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
domeif46ysefptf04t
17 Apr 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
ajh009dnutdf
30 Mar 20
Departure of Directors or Certain Officers
4:16pm
8-K
17u3f
16 Mar 20
Seelos Therapeutics Announces Closing of Public Offering of Common Stock
4:30pm
424B5
e0xwsuxcf50e2hcx2
12 Mar 20
Prospectus supplement for primary offering
5:27pm
8-K
68kw 2r7opgml9
12 Mar 20
Seelos Therapeutics Announces Pricing of $4.5 Million Public Offering of Common Stock
5:24pm
424B5
8159lromip8u1nh
11 Mar 20
Prospectus supplement for primary offering
4:18pm
CT ORDER
dtzhwvtgw58m
6 Mar 20
Confidential treatment order
9:38am
8-K
mr9vm8fpk31
13 Feb 20
Seelos Therapeutics Announces Closing of Public Offering of Common Stock
4:30pm
EFFECT
itzxt
12 Feb 20
Notice of effectiveness
12:15am
424B4
69r9ikr
11 Feb 20
Prospectus supplement with pricing info
5:14pm
8-K
5hw5a ie9uh
11 Feb 20
Seelos Therapeutics Announces Pricing of $5 Million Public Offering of Common Stock
6:08am
CORRESP
4p7tyrz6ulb
3 Feb 20
Correspondence with SEC
12:00am
CORRESP
nwiu imme3jfwpu73k4
3 Feb 20
Correspondence with SEC
12:00am
FWP
bz7m647
29 Jan 20
Free writing prospectus
9:33pm